ANORO ELLIPTA®

Drug Information Related Patent
Hold Company
GLAXOSMITHKLINE
Learn More
Dosage and Administration
POWDER; INHALATION
Specification
EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH
Indication
ANORO ELLIPTA® is used for patients with chronic obstructive pulmonary disease (COPD) maintenance therapy.
Use
Instructions for Use
API
UMECLIDINIUM BROMIDE
VILANTEROL TRIFENATATE
API Structure
We Supply
UMECLIDINIUM BROMIDE
Note:

Commercial

VILANTEROL TRIFENATATE
Note:

Commercial

null
Note:

null

Drug Patent
Patent NoExpiration Date
110902942030/11/29
74393932025/5/21
74888272027/12/18
74984402025/4/27
81131992027/10/23
81619682028/2/5
81832572025/7/27
83095722025/4/27
85113042027/6/14
85342812030/3/8
87462422030/10/11
93333102027/10/2
97507262030/11/29
API Patent
Patent NoExpiration Date
74393932025/5/21
74888272027/12/18
74984402025/4/27
81832572025/7/27
83095722025/4/27
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
dcat
Member of
dcat
Top